CSI Cardiovascular Systems, Inc., Diamondback 360 Peripheral Orbital Atherectomy System, Model Number DBP-125MICRO145, Part Number 7-10003. The Diamondback 360 Peripheral Orbital Atherectomy System is a percutaneous orbital atherectomy system indicated for use as therapy in patients with occlusive atherosclerotic disease in peripheral arteries and who are acceptable candidates for percutaneous transluminal atherectomy. The OAS supports removal of stenotic material from artificial arteriovenous dialysis fistulae (AV shunt). The system is a percutaneous orbital atherectomy system indicated as a therapy in patients with occluded hemodialysis grafts who are acceptable candidates for percutaneous transluminal angioplasty.
Published August 20, 2014 · Recall initiated: May 23, 2014
Summary
FDA records medical device Class I recall Z-2155-2014, published August 20, 2014 and initiated May 23, 2014. Recalling firm: Cardiovascular Systems, Inc.; Status: Terminated; Reported quantity: 48; Lot: 100573, 100575, 100674, 100676, 100678, 100680. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CSI has initiated a recall on the Diamondback 360 Peripheral Orbital Atherectomy Device because it may contain a saline sheath that may experience cracking, fracture, and release particulate during use.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Cardiovascular Systems, Inc.
- Distributor
- Nationwide Distribution including AZ, AR, CA, CT, FL, IL, IA, MD, MI, NY, NC, PA, TN,and TX.
- Lot
- 100573, 100575, 100674, 100676, 100678, 100680.
- Risk classification
- Class I
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDADiamondback 360 Coronary Orbital Atherectomy System, Model Number: DBEC-125. The system is indicated toApril 1, 2015
- FDAEnhancement Medical expression. model # EXP-150. Injectable Gel 1.5cc Syringe with hyaluronic acidAugust 20, 2014
- FDAEsaote PA230E Transducer A portable and cart base ultrasound system for general and cardiovascular imagingAugust 20, 2014
- FDAGYC-1000 Green Laser Photocoagulator system The Nidek Green Laser Photocoagulator Model GYC -1000 is indicatedAugust 20, 2014
- FDACSI, Diamondback 360 Coronary Orbital Atherectomy System, Part Number 70058-02, Model Number DBEC-125 ProductMarch 5, 2014
- FDACSI Stealth 360-degree Orbital Atherectomy Device (OAD), Part Number 70056-11, Model Number PRD-SC30-125S.July 18, 2012
Questions about this recall
Was CSI Cardiovascular Systems, Inc., Diamondback 360 Peripheral Orbital Atherectomy System, Model Number DBP-125MICRO145, Part Number 7-10003. The Diamondback 360 Peripheral Orbital Atherectomy System is a percutaneous orbital atherectomy system indicated for use as therapy in patients with occlusive atherosclerotic disease in peripheral arteries and who are acceptable candidates for percutaneous transluminal atherectomy. The OAS supports removal of stenotic material from artificial arteriovenous dialysis fistulae (AV shunt). The system is a percutaneous orbital atherectomy system indicated as a therapy in patients with occluded hemodialysis grafts who are acceptable candidates for percutaneous transluminal angioplasty. recalled?
Yes. FDA published recall Z-2155-2014 on August 20, 2014. Reported hazard: CSI has initiated a recall on the Diamondback 360 Peripheral Orbital Atherectomy Device because it may contain a saline sheath that may experience cracking, fracture, and release particulate during use.
What should I do if I have this product?
Voluntary: Firm initiated · Letter